Biosimilarsverband Österreich

the “biosimilarsverband österreich“ is a voluntary representative of the interests of biosimilars providers and producers. biosimilars are equivalent “follow-up products” of biopharmaceuticals that have been admitted on the market for many years, but whose patents have expired. therefore, they are an affordable alternative for expensive therapies. our goal: providing access to innovative biopharmaceutical drug therapies for patients that are sustainably affordable. our members are a-med gmbh, amgen gmbh, astro pharma gmbh, mylan pharma, ratiopharm arzneimittel vertriebs gmbh, sandoz gmbh und stada arzneimittel gmbh. these companies covered more than 85% of the austrian biosimilar market in 2016. our goals: • providing educational work around the equivalence of the effect and security of a biosimilar in comparison to the original pharmaceutical product. • providing patients with an appropriate access to modern biopharmaceutical drug therapies and making them financially affordable.